| Literature DB >> 16252004 |
Nikolaus Thuille1, Isabelle Heit, Friedrich Fresser, Nina Krumböck, Birgit Bauer, Sabine Leuthaeusser, Sascha Dammeier, Caroline Graham, Terry D Copeland, Steve Shaw, Gottfried Baier.
Abstract
Phosphopeptide mapping identified a major autophosphorylation site, phospho (p)Thr-219, between the tandem C1 domains of the regulatory fragment in protein kinase C (PKC)theta. Confirmation of this identification was derived using (p)Thr-219 antisera that reacted with endogenous PKCtheta in primary CD3+ T cells after stimulation with phorbol ester, anti-CD3 or vanadate. The T219A mutation abrogated the capacity of PKCtheta to mediate NF-kappaB, NF-AT and interleukin-2 promoter transactivation, and reduced PKCtheta's ability in Jurkat T cells to phosphorylate endogenous cellular substrates. In particular, the T219A mutation impaired crosstalk of PKCtheta with Akt/PKBalpha in NF-kappaB activation. Yet, this novel (p)Thr-219 site did not affect catalytic activity or second-messenger lipid-binding activity in vitro. Instead, the T219A mutation prevented proper recruitment of PKCtheta in activated T cells. The PKCthetaT219A mutant defects were largely rescued by addition of a myristoylation signal to force its proper membrane localization. We conclude that autophosphorylation of PKCtheta at Thr-219 plays an important role in the correct targeting and cellular function of PKCtheta upon antigen receptor ligation.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16252004 PMCID: PMC1283955 DOI: 10.1038/sj.emboj.7600856
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598